|Systematic (IUPAC) name|
|Mol. mass||351.363 g/mol|
Benfluorex is an anorectic and hypolipidemic agent. Clinical studies have shown it may improve glycemic control and decrease insulin resistance in people with poorly controlled type 2 diabetes; it is marketed in France as an adjuvant antidiabetic.
Benfluorex is structurally related to fenfluramine.
Benfluorex has been baned in France and the European Union because of links to thickening of heart valves and heart attacks.
<ref>tags exist, but no
<references/>tag was found
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies